Learning pointsConstrictive pericarditis may occur with the healing of acute fibrinous, serofibrinous pericarditis or chronic pericardial effusion, which in turn results in obliteration of the pericardial cavity and formation of granulation tissue.Chylothorax is an uncommon clinical condition, usually associated with trauma or neoplasm.Chylothorax due to constrictive pericarditis is rare. It may result from increased effective capillary infiltration secondary to central venous hypertension and reduced lymphatic drainage due to high pressure in the left subclavian vein.

Introduction
============

Acute pericarditis is a common finding in patients evaluated for chest pain. There are numerous possible causes, both infectious and non-infectious. An infrequent consequence is constrictive pericarditis. Similarly, pleural effusion is common in hospitalized patients, with numerous aetiologies. A rare cause of pleural effusion is chylothorax, attributed to a damaged thoracic duct and characterized by a milky white pleural effusion rich in triglycerides. The damage is most commonly due to trauma or malignancy, particularly lymphomas. However, it has been postulated that any cardiac cause of elevated right-sided venous pressure may potentially lead to chylothorax.

Timeline
========

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Initial presentation Gradual onset of chest pain and dyspnoea with elevated C-reactive protein (CRP) and D-dimer. Chest X-ray revealed pleural effusion, and echocardiogram was consistent with effusive constrictive pericarditis. Administration of anti-inflammatory treatment (naproxen + colchicine) was started.
  Next 8 months: Repeated echocardiography showed regress of pericardial fluid, but persistent constrictive haemodynamics. Right-sided pleural effusion recurred regularly with need of a total of 15 pleurocenteses. Comprehensive investigations did not reveal any underlying aetiology. Cardiac magnetic resonance imaging (MRI) showed persistent pericardial inflammation. Treatment with diuretics, steroids, and eventually the interleukin-1 antagonist anakinra was added. The extensive anti-inflammatory treatment had no effect on symptoms, constrictive haemodynamics, or the recurrence of pleural fluid. However, the systemic inflammatory response did diminish with normalized CRP and D-dimer.
  Transfer to university hospital after 9 months: Echocardiography, cardiac MRI, and cardiac catheterization with simultaneous left- and right-sided pressure recordings confirmed constrictive pericarditis. No aetiology of the constrictive pericarditis was found.
  Right-sided pleurocentesis demonstrated chylothorax. Lymphoscintigraphy was normal with no signs of physical damage to the thoracic duct or its major branches. Computed tomography scans did not reveal any malignancy or lymphadenopathy.
  After total pericardiectomy there was rapid resolution of symptoms, pleural effusion, and chylothorax.
  Post-operative controls 3 and 6 months later: Following pericardiectomy, clinical improvement was substantial and the patient resumed full-time physical work. Pleural effusion did not recur, and echocardiograms were normal without evidence of constrictive haemodynamics.
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Case report
===========

A previously healthy 63-year-old man presented to the local hospital with a 1 month history of chest pain and dyspnoea on exertion. Blood pressure was 140/70 mmHg; heart rate regular at 105 b.p.m., with no distention of neck veins, heart murmurs, or peripheral oedemas. There were reduced breath sounds at the lung bases. ECG showed sinus tachycardia with general T-wave inversions. Initial laboratory tests, including haematology, electrolytes, and troponin T were negative. C-reactive protein (CRP) was elevated to 40 mg/L (normal range 0--4 mg/L). D-dimer was \>4 mg/L (normal reference \<0.5 mg/L). Computed tomography (CT) pulmonary angiogram was negative for pulmonary embolism, but showed bilateral pleural effusions and moderate pericardial effusion (*Figure [2](#yty113-F2){ref-type="fig"}A*). Transthoracic echocardiogram demonstrated pericardial thickening and effusion, normal ventricular dimensions with good contractility, bi-atrial enlargement, and a distended inferior vena cava without diameter changes on respiration. Doppler recordings demonstrated marked reciprocal respiratory variations in right ventricle (RV) and left ventricle (LV) diastolic inflow velocities, annulus paradoxus, and septal bounce, consistent with the diagnosis of effusive-constrictive pericarditis (*Figure [1](#yty113-F1){ref-type="fig"}A*--*F*). Comprehensive testing for infectious or immunological causes were negative (*Table [1](#yty113-T1){ref-type="table"}*). Anti-inflammatory treatment \[naproxen 500 mg twice a day (b.i.d) and colchicine 0.5 mg b.i.d\] was initiated, with a follow-up plan at the outpatient clinic. Table 1Analyses of serum and pleural fluidSerology: normal haemogram, CRP 40 mg/L, troponin T 14--\<10 ng/L, pro-BNP 148 ng/L, and d-dimer \>4 mg/LMicrobiology: negative: HIV, HCV, HHV6, and Borrelia IgG/IgMPCR: negative for M. tuberculosis-complex, adenovirus, CMV, EBV, enterovirus, and coxiellaRheumatology: negative ANA/ANCA, RF, anti-GBM, normal IgE and IgG+ subclasses, and normal C3 and C4Pleural effusion at second admission: pale yellow, transudate. PH 7.51, glucose 6 mmol/L, albumin 18 g/L, protein 29 g/L, LD 158 U/L, LD/protein ratio 0.5. The cytology for malignant cells: negativeNegative for culture of pyogenic organisms as well as M. tuberculosis in serum and pleural effusionMicroscopy by gram and ZN stain revealed negative results[^1]

![(*A*) Pericardial thickening and effusion. (*B*) Inferior vena cava plethora. Dilated hepatic veins with diastolic flow reversal during expiration (not shown). (*C*, *D*) Marked reciprocal respiratory variations in LV and RV diastolic inflow velocities. Pulsed wave tissue Doppler recordings at the septal (*E*) and lateral (*F*) mitral annulus (*E′*, asterisks; septal 20 cm/s, lateral 10 cm/s): annulus paradoxus. LV, left ventricle; RV, right ventricle.](yty113f1){#yty113-F1}

![(*A*) Chest computed tomography at first admission: bilateral pleural effusion; right side 5 cm and left side 3 cm. Pericardial effusion 9 mm. (*B*) Chest X-ray at second admission: massive right-sided pleural effusion. (*C*) Cardiac magnetic resonance imaging, with pericardial gadolinium contrast enhancement (arrow). (*D*) Chest X-ray at post-operative control.](yty113f2){#yty113-F2}

One month later, the patient's symptoms returned, now also including bilateral leg oedema and distended neck veins. Chest X-ray revealed massive right-sided pleural effusion (*Figure [2](#yty113-F2){ref-type="fig"}B*), and drainage was performed. Analysis of the pleural fluid showed a transudate, with negative tests for malignant cells or microbiological aetiology (*Table [1](#yty113-T1){ref-type="table"}*). Thoracic and abdominal CT scans showed no evidence of malignancy or lymphadenopathies. Repeat echocardiography revealed regression of pericardial effusion, and persistent constrictive haemodynamics.

Despite 3 months of anti-inflammatory treatment and diuretics the condition did not improve. Cardiac magnetic resonance imaging (MRI) showed pericardial thickening and late pericardial contrast enhancement after intravenous gadolinium, findings consistent with active pericardial inflammation (*Figure [2](#yty113-F2){ref-type="fig"}C*). Comprehensive testing for infectious or immunological causes were still negative, and a corticosteroid was added (prednisolone 40 mg q.d). Due to the suspicion of an ongoing inflammatory or immunological process, additional therapy with anakinra (sc 100 mg q.d) was initiated 2 months later, still without clinical response. During the following 6 months of treatment, the patient suffered from recurrent symptomatic right-sided pleural effusion, with the need of a total of 15 pleurocenteses. Approximately 60 L of pleural fluid was drained during this period.

The patient was referred to the University Hospital for further evaluation and treatment. Echocardiography, cardiac MRI, and simultaneous left and right catheterization confirmed the presence of constrictive pericarditis (*Figure [3](#yty113-F3){ref-type="fig"}A*). There was consistent pericardial thickening. At this point, pericardial effusion was minimal and laboratory findings were normalized with CRP levels \<5 mg/L and D-dimer \<0.5 mg/L. Drainage of recurrent right-sided pleural effusion now demonstrated a milky/yellowish fluid (*Figure [3](#yty113-F3){ref-type="fig"}B*). Analysis of the pleural fluid still revealed a transudate but with strikingly elevated triglyceride levels of 4.5 mmol/L (normal reference \<1.24 mmol/L) and cholesterol level 1.6 mmol/L (normal reference \<5.18 mmol/L), findings diagnostic for chylothorax. Lymphoscintigraphy was normal, with no signs of damage to the thoracic duct or its major branches. In view of chronic constrictive pericarditis with no response to medical therapy and probable secondary chylothorax, the patient was scheduled for surgical pericardiectomy. A complete pericardiectomy through a median sternotomy was performed. Resection of the pericardium extended beyond the left, right, and inferior cardiac border, to the great vessels superiorly and to the diaphragmatic surface and inferior vena cava inferiorly.

![(*A*) Elevated and equalized diastolic pressure in all chambers. Simultaneous RV and LV pressure trace show early dip followed by plateauing of pressure in mid-diastole, the 'square root sign'. During inspiration peak systolic pressure in LV was reduced with corresponding increase in systolic RV pressure, with the opposite changes during expiration. Significantly elevated RA pressure: 24 mmHg. (*B*) Turbid pleural aspirate, white/yellow colour. (*C*) Biopsy: pericardial fibrosis with calcifications, and no granulomas or carcinomatosis. LV, left ventricle; RA, right atrial; RV, right ventricle.](yty113f3){#yty113-F3}

Operative findings demonstrated a calcified, thickened pericardium, with adhesion to the heart. The heart immediately expanded and the heart rate decreased. Histopathological findings showed pericardial fibrosis with calcifications, while there were no granulomas or carcinomatosis (*Figure [3](#yty113-F3){ref-type="fig"}C*). Tissue cultures for bacteria, fungi, and mycobacteria were negative. The patient was discharged, anti-inflammatory treatment stopped and corticosteroids gradually withdrawn. During outpatient follow-up 3 and 6 months post-operative, clinical improvement was substantial and the patient resumed full-time physical work. The pleural effusion did not recur (*Figure [2](#yty113-F2){ref-type="fig"}D*). Echocardiograms were normal without evidence of constrictive haemodynamics and normal ventricular interdependence.

Discussion
==========

Constrictive pericarditis is a chronic inflammatory process leading to pericardial fibrosis, encasing the heart in a fibrotic and usually thickened pericardium. This causes impaired diastolic cardiac function leading to heart failure. Pulmonary congestion is usually not a feature because of reduced right-sided output from compression.[@yty113-B1]

The constraining pericardium results in fixed total cardiac volume and prevents normal transmission of thoracic pressures to the cardiac chambers. The stiff pericardium limits the expansion of the heart, causing elevation, and equalization of diastolic pressures in all cardiac chambers, including caval and pulmonary veins. Furthermore, the fixed cardiac volume necessitates enhanced ventricular interdependence to maintain cardiac output.[@yty113-B2]^,^[@yty113-B3]

Chylothorax is a rare condition with accumulation of chyle in the pleural cavity. The condition is suggested by aspiration of milky white pleural fluid. Pleural effusion with triglyceride levels \>1.24 mmol/L (110 mg/dL) and cholesterol levels \<5.18 mmol/L (200 mg/dL) are diagnostic of chylothorax. As approximately 2.4 L of chyle is transported through the lymphatic system every day, damage or obstruction of the duct can give rise to a large and rapid accumulation of chyle in the pleural space.[@yty113-B4] Traumatic cases constitute approximately 50% of cases of chylothorax and can be sub-classified as iatrogenic (80%, with cardiothoracic surgery as the leading cause) or non-iatrogenic (20%, with rupture after childbirth, vomiting, and gunshot as common causes). Non-traumatic aetiologies include malignancy (30%), most frequently lymphoma, representing the second most frequent cause of chylothoraces.[@yty113-B5] Other causes include sarcoidosis, inferior vena cava thrombosis, liver cirrhosis, nephrotic syndrome, right heart failure, and diseases of the lymph vessels. Chylothoraces are typically exudative in 86% and transudative in 14% of cases.[@yty113-B6] The transudative profile was found in patients with cirrhosis, nephrotic syndrome, and right heart failure.[@yty113-B7]

Pleural effusions may be found with constrictive pericarditis.[@yty113-B8] However, there are very few reports of chylothorax due to constrictive pericarditis. Explanatory hypotheses postulate that increased systemic venous pressure leads to increased effective capillary filtration and consequently increased lymph production. Furthermore, if pressure rises in the superior vena cava, a parallel increase of pressure can be observed in the thoracic duct.[@yty113-B9] In constrictive pericarditis there is increased pressure in the cervical veins, causing a functional obstacle to the drainage of lymph flow from the thoracic duct. This impairment of thoracic duct outflow might contribute to leakage of chyle in the pleural cavity through hydrostatic forces.[@yty113-B10]

Our patient with constrictive pericarditis presented eventually with chylothorax. The effusive-constrictive pericarditis might have been caused by an acute inflammatory process, and developed to a chronic constrictive pericarditis. Even though the constriction did not resolve on medical treatment, the systemic inflammatory response diminished. Nevertheless, despite comprehensive assessment, no single aetiological cause could be identified.

Conclusion
==========

This case demonstrates a rare concomitance of constrictive pericarditis and chylothorax.

The rapid and lasting resolution of pleural effusion following pericardiectomy strongly suggests that our patient's chylothorax was indeed secondary to constrictive pericarditis.
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[^1]: ANA/ANCA, antinuclear antibody/antineutrophil cytoplasmic antibody; anti-GBM, anti-glomerular basement membrane antibody; CMV, cytomegalovirus; EBV, Epstein-Barr virus; HCV, hepatitis C; HHV-6, human herpesvirus 6; LD, lactic dehydrogenase; RF, rheumatoid factor; ZN, Ziehl-Neelsen.
